ADHD News & Research
Return to Xelstrym to Launch Soon: New FDA-Approved ADHD Stimulant Patch

Xelstrym to Launch Soon: New FDA-Approved ADHD Stimulant Patch

Xelstrym is the first FDA-approved transdermal amphetamine patch to treat pediatric and adult patients with ADHD. It is expected to launch later this year.

There are no comments.

Leave a Reply